Cargando…

The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study

BACKGROUND: Alcohol is the main cause of chronic liver disease. The Enhanced Liver Fibrosis (ELF) test is a serological biomarker for fibrosis staging in chronic liver disease, however its utility in alcohol-related liver disease warrants further validation. We assessed the diagnostic and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Connoley, Declan, Patel, Preya Janubhai, Hogan, Brian, Tanwar, Sudeep, Rhodes, Freya, Parkes, Julie, Burt, Alastair, Watkins, Jennifer, Sievert, William, Rosenberg, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240375/ https://www.ncbi.nlm.nih.gov/pubmed/34182924 http://dx.doi.org/10.1186/s12876-021-01795-5

Ejemplares similares

Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
por: Tanwar, Sudeep, et al.
Publicado: (2020)

Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests
por: Rhodes, Freya Alison, et al.
Publicado: (2021)

Uncovering unsuspected advanced liver fibrosis in patients referred to alcohol nurse specialists using the ELF test
por: Rhodes, Freya, et al.
Publicado: (2021)

The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
por: Trembling, Paul M., et al.
Publicado: (2020)

Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease
por: Parkes, Julie, et al.
Publicado: (2012)

Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
por: Srivastava, Ankur, et al.
Publicado: (2019)

Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection
por: Trembling, P M, et al.
Publicado: (2014)

A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care
por: Patel, PreyaJanubhai, et al.
Publicado: (2018)

Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Trembling, Paul M, et al.
Publicado: (2017)

Human Amnion Epithelial Cells Produce Soluble Factors that Enhance Liver Repair by Reducing Fibrosis While Maintaining Regeneration in a Model of Chronic Liver Injury
por: Hodge, Alexander, et al.
Publicado: (2020)

The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?
por: Cococcia, Sara, et al.
Publicado: (2022)

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
por: Irvine, Katharine M., et al.
Publicado: (2021)

Cytoplasmic domain of tissue factor promotes liver fibrosis in mice
por: Knight, Virginia, et al.
Publicado: (2017)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
por: Friedrich-Rust, Mireen, et al.
Publicado: (2010)

Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease
por: Braude, Michael, et al.
Publicado: (2022)

A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis
por: Mathew, Joseph, et al.
Publicado: (2005)

Non-invasive assessment of liver fibrosis in alcoholic liver disease
por: Husain, Ayan, et al.
Publicado: (2020)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography
por: Wahl, Kristin, et al.
Publicado: (2012)

Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells
por: Goonetilleke, Mihiri, et al.
Publicado: (2021)

Ascites in Early Alcoholic Cirrhosis of the Liver
por: Weber, F. Parkes
Publicado: (1903)

Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B
por: Hodge, Alexander, et al.
Publicado: (2017)

The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis
por: Alhomrani, Majid, et al.
Publicado: (2017)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics
por: Chrostek, Lech, et al.
Publicado: (2019)

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests
por: Johnson, Amy L., et al.
Publicado: (2021)

Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism
por: Radford-Smith, Daniel E., et al.
Publicado: (2022)

Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Honda, Yasushi, et al.
Publicado: (2020)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
por: Soto, Marcelo, et al.
Publicado: (2017)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
por: Challa, Tenagne D, et al.
Publicado: (2019)

Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Alazawi, William, et al.
Publicado: (2017)

Acoustic radiation force impulse elastography of liver as a screening tool for liver fibrosis in alcoholic liver disease
por: Hittalamani, Iranna M, et al.
Publicado: (2019)

P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis
por: Xia, Guo-Qing, et al.
Publicado: (2022)

Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
por: Zeybel, Müjdat, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5j8pcpjncoq1os6g983jtaokg3